**Meta:** Zydus Lifesciences aims to acquire Amplitude Surgical for €256.8 million, marking its entry into the global medtech market.
**Content:**
### Zydus Lifesciences Enters Negotiations to Acquire Amplitude Surgical
**Who:** Zydus Lifesciences, a pharmaceutical company based in Ahmedabad, India.
**What:** Exclusive negotiations to acquire a controlling stake in Amplitude Surgical SA, a French medtech firm.
**When:** Announcement made on Tuesday.
**Where:** The acquisition involves Amplitude Surgical, headquartered in France.
**Why:** To expand Zydus’s presence in the global medical devices market.
Zydus Lifesciences is negotiating to purchase an 85.6% stake in Amplitude Surgical for €256.8 million from PAI Partners, the management of Amplitude, and two minority shareholders. Following this acquisition, Zydus plans to make a mandatory cash offer for the remaining shares, bringing the total potential acquisition value to €300 million.
### Expansion into Global Medtech
Managing Director Sharvil Patel stated, “With this, we will be making a foray into the global medtech space. We want to offer services beyond just medicines, whether it is medical devices which are highly technologically oriented or companion diagnostics… areas where we feel better patient outcomes can be seen.”
– Zydus’s offer price of €6.25 per equity share represents an 81% premium over Amplitude’s last closing price.
– Amplitude Surgical specializes in surgical technologies for lower limb orthopaedics, developing high-end products for hip and knee surgeries.
### Financial Performance of Amplitude Surgical
In the fiscal year ending June 30, 2024, Amplitude Surgical reported:
– Sales of €106 million
– Earnings before interest, taxes, depreciation, and amortization (EBITDA) of €27.1 million
### Market Opportunities in Medical Devices
Zydus sees significant growth potential in the medical devices sector, focusing on three key areas:
– Orthopaedics
– Interventional cardiology
– Nephrology
Patel highlighted the current imbalance in India’s medical device market, stating, “Today, there is a high burden of import versus export [in India] and there is a big skew towards a large amount of imports related to medical devices and medical technology.”
– India’s medical devices exports grew at a compound annual growth rate of 14%, reaching $3.8 billion in FY24.
– However, India remains a net importer, with imports totaling $8.2 billion in FY24, a 13% increase from the previous year.
### Conclusion
As Zydus Lifesciences moves forward with this acquisition, how will it reshape the landscape of the medical devices market in India and globally?
**FAQs:**
**Q: What is the value of Zydus Lifesciences’ acquisition of Amplitude Surgical?**
A: Zydus Lifesciences is negotiating to acquire a controlling stake in Amplitude Surgical for €256.8 million, with a potential total acquisition value of €300 million.
**Alt Text:** Zydus Lifesciences negotiating acquisition of Amplitude Surgical.
**URL Slug:** zydus-lifesciences-acquisition-amplitude-surgical
